Seeking Men and Women over 18 years old who have a certain type of Stage III Non-Small Cell Lung Cancer (NSCLC).
We are studying to • See how well the study drug, pembrolizumab together with 2 different chemotherapy combinations and radiotherapy • Test the safety of the study drug • See how your body handles the study drug
What we're hoping for
We are hoping that the subjects will benefit from the standard of care treatment a well as the study drug. Information learned from the study may help other people in the future.
ClinicalTrials.gov Identifier: NCT03631784